Clinical Topics & News

Depression Screening and Treatment: A Missed Opportunity in Lung Cancer Care

Author and Disclosure Information

 

References

Overall, there is minimal evidence that depression treatment can improve lung cancer survival; however, the lack of high-quality studies is a considerable limitation. Given the significant impact of depression on survival among patients with lung cancer, additional funding and resources are urgently needed to combat this debilitating comorbid disease.

Acknowledgments
This project was supported in part by the National Cancer Institute of the National Institutes of Health under award K07CA190706 to Dr. Sullivan, a Career Development Award from the Veterans Health Administration Health Service Research and Development (CDA 14-428) to Dr. Teo and the HSR&D Center to Improve Veteran Involvement in Care (CIVIC) (CIN 13-404) at the VA Portland Health Care System.

Author disclosures
The authors report no actual or potential conflicts of interest with regard to this article.

Disclaimer
The VA had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication. The opinions expressed herein are those of the authors and do not necessarily reflect those of
Federal Practitioner, Frontline Medical Communications Inc., the U.S. Government, or any of its agencies.

Click here to read the digital edition.

Pages

Recommended Reading

Lung Cancer Screening: Translating Research Into Practice (FULL)
AVAHO
Navigator Driven Process to Coordinate Multi-Disciplinary Visits for Advanced Lung Cancer Patients
AVAHO
Abdominal Compression by Prone Position in Lung SBRT— A Technical Note
AVAHO
VA Partnership Expands Access to Lung Screening Programs
AVAHO
Timeliness of Lung Cancer Diagnosis and Treatment (FULL)
AVAHO
Clinical Puzzle: Lung Cancer or Hodgkin Lymphoma?
AVAHO
Nivolumab plus ipilimumab boosts PFS in advanced NSCLC with high tumor mutational burden
AVAHO
Former Smokers Motivate Quitters
AVAHO
Trio of biosimilars have good showing
AVAHO
Rapid EGFR testing reduces time to therapy for patients with NSCLC
AVAHO